Jupiter Neurosciences (JUNS) Enterprise Value (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Enterprise Value of -$723797.0 for Q3 2025, down 285985.77% year-over-year from N/an in Q3 2024, and up 61.46% quarter-over-quarter from -$1.9 million in Q2 2025.
Jupiter Neurosciences (JUNS) Enterprise Value (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Enterprise Value for 3 consecutive years, with -$723797.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Enterprise Value fell 285985.77% year-over-year to -$723797.0; the TTM figure through Sep 2025 stood at -$723797.0 (down 285985.77% YoY), while the FY2024 annual figure was -$3.8 million, down 13136.57% from the prior year.
- Enterprise Value climbed to -$723797.0 in Q3 2025 per JUNS's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$253.0 in Q3 2024 and bottomed at -$3.8 million in Q4 2024.
- Historically, Enterprise Value has averaged -$1.0 million across 3 years, with a median of -$59615.0 in 2023.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 99.58% — and 2025, when it slumped 285985.77%.
- Jupiter Neurosciences' Enterprise Value stood at -$28478.0 in 2023, then plunged by 13136.57% to -$3.8 million in 2024, then jumped by 80.8% to -$723797.0 in 2025.
- Business Quant data shows JUNS's Enterprise Value at -$723797.0 in Q3 2025, -$1.9 million in Q2 2025, and -$2.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -723,797.00 |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | -3.77 Mn |
| Sep 30, 2024 | -253.00 |
| Jun 30, 2024 | -14,851.00 |
| Mar 31, 2024 | -8,313.00 |
| Dec 31, 2023 | -28,478.00 |
| Sep 30, 2023 | -59,615.00 |